Meta‐analysis: factors predicting post‐operative recurrence with placebo therapy in patients with Crohn’s disease
Open Access
- 31 July 2008
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 28 (5), 545-556
- https://doi.org/10.1111/j.1365-2036.2008.03774.x
Abstract
Background The use of placebo in randomized clinical trials (PC‐RCTs) is often required to evaluate drug efficacy in maintenance of Crohn’s disease (CD). Aim To determine pooled estimates of placebo rates of maintaining clinical remission and endoscopic recurrence following surgery for CD and identify factors that influenced placebo outcomes. Methods We performed a systematic review and meta‐analysis of PC‐RCTs evaluating post‐operative maintenance therapies for CD identified from MEDLINE from 1966 to 2005. Results Twelve studies met our inclusion criteria. The pooled placebo rate of maintaining clinical remission was 56% (95% CI 47–64%; range 34–89%) during a median follow‐up of 52 weeks (range 12–156 weeks), but significant heterogeneity existed among the studies (P < 0.001). Prior steroid therapy was the only factor found to be associated with maintaining remission (P = 0.04). The pooled placebo endoscopic recurrence rate was 58% (95% CI 51–65%; range 36–80%) during a median follow‐up of 52 weeks (range 12–156 weeks), with significant heterogeneity noted (P = 0.0003). Prior surgery, concomitant small bowel and colonic disease, fistulizing phenotype, or prior immunomodulator therapy influenced endoscopic recurrence (P < 0.05). Conclusion Placebo rates in PC‐RCTs evaluating post‐operative clinical and endoscopic recurrence demonstrate significant variability, which is influenced by specific study characteristics.Keywords
This publication has 22 references indexed in Scilit:
- A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on AzathioprineGastroenterology, 2005
- Low-dose budesonide treatment for prevention of postoperative recurrence of Crohnʼs diseaseEuropean Journal of Gastroenterology & Hepatology, 1999
- Oral budesonide for prevention of postsurgical recurrence in Crohn's diseaseGastroenterology, 1999
- Factors influencing recurrence in Crohn's diseaseDiseases of the Colon & Rectum, 1996
- Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohnʼs diseaseEuropean Journal of Gastroenterology & Hepatology, 1996
- Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's diseaseGastroenterology, 1995
- Controlled trial of metronidazole treatment for prevention of crohn's recurrence after ileal resectionGastroenterology, 1995
- Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's diseaseGastroenterology, 1995
- Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms.Gut, 1988
- Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery.Gut, 1984